Video: Reconstituting Valproic Acid (VPA) for Reprogramming

Mapping the Competitive Landscape of Human Tissue-Based Drug Discovery

Explore how REPROCELL leads in human tissue-based drug discovery, addressing market gaps and offering innovative, disease-relevant solutions for better therapeutic outcomes.

02 April 2026

5 Hard Truths About Bringing Stem Cell Therapies to the Clinic

Discover the essential truths behind developing clinical-grade stem cell therapies and learn how to navigate the complexities of GMP manufacturing successfully.

30 March 2026

Donor Variability in Ex Vivo Human Tissue Studies: Challenge, Feature, or Translational Advantage

Explore how donor variability in ex vivo human tissue studies enhances translational research by providing insights into patient heterogeneity and improving drug discovery.

12 March 2026

REPROCELL Attends Japan-Maryland Night 2026

REPROCELL was honored to attend Japan-Maryland Night on Wednesday March 4th 2026  Maryland State, USA, hosted by the Embassy of Japan (in Washington DC).

06 March 2026